Selected research
Industry Research
Microphysiological System Industry Research Report 2026
Market perspective
The global Microphysiological System market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Microphysiological System market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Microphysiological System market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Microphysiological System market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Microphysiological System include Emulate, Mimetas, TissUse, InSphero, Hesperos, CN Bio, TNO, 28bio and Beijing Daxiang Biotech, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global Microphysiological System market in terms of revenue (US$ million) and, where applicable, service volume (K Units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Microphysiological System.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Microphysiological System Market by Company
Emulate
Mimetas
TissUse
InSphero
Hesperos
CN Bio
TNO
28bio
Beijing Daxiang Biotech
Newcells Biotech
Nortis (Quris-Al)
Valo Health (TARA Biosystems)
Altis Biosystems
Draper Laboratory
Netri
Bi/ond
ImmuONE
AlveoliX
Cherry Biotech
Ananda Devices
Obatala Sciences
BiomimX
React4life
Aracari Bio
StemPharm
SynVivo
Microphysiological System Segment by Type
Human Organ and Tissue Models
Disease Models
Non-Human Species Models
Microphysiological System Segment by Application
Pharmaceutical & Biotechnology Companies
Academic & Research Institutes
Others
Microphysiological System Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Microphysiological System market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Microphysiological System and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Microphysiological System.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Microphysiological System companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Human Organ and Tissue Models
- Disease Models
- Non-Human Species Models
Applications
- Pharmaceutical & Biotechnology Companies
- Academic & Research Institutes
- Others
Companies covered
- Emulate
- Mimetas
- TissUse
- InSphero
- Hesperos
- CN Bio
- TNO
- 28bio
- Beijing Daxiang Biotech
- Newcells Biotech
- Nortis (Quris-Al)
- Valo Health (TARA Biosystems)
- Altis Biosystems
- Draper Laboratory
- Netri
- Bi/ond
- ImmuONE
- AlveoliX
- Cherry Biotech
- Ananda Devices
- Obatala Sciences
- BiomimX
- React4life
- Aracari Bio
- StemPharm
- SynVivo
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Microphysiological System by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Human Organ and Tissue Models
- 2.2.3 Disease Models
- 2.2.4 Non-Human Species Models
- 2.3 Microphysiological System by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Pharmaceutical & Biotechnology Companies
- 2.3.3 Academic & Research Institutes
- 2.3.4 Others
- 2.4 Assumptions and Limitations
3 Microphysiological System Breakdown Data by Type
- 3.1 Global Microphysiological System Historic Market Size by Type (2021-2026)
- 3.2 Global Microphysiological System Forecasted Market Size by Type (2027-2032)
4 Microphysiological System Breakdown Data by Application
- 4.1 Global Microphysiological System Historic Market Size by Application (2021-2026)
- 4.2 Global Microphysiological System Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Microphysiological System Market Perspective (2021-2032)
- 5.2 Global Microphysiological System Growth Trends by Region
- 5.2.1 Global Microphysiological System Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Microphysiological System Historic Market Size by Region (2021-2026)
- 5.2.3 Microphysiological System Forecasted Market Size by Region (2027-2032)
- 5.3 Microphysiological System Market Dynamics
- 5.3.1 Microphysiological System Industry Trends
- 5.3.2 Microphysiological System Market Drivers
- 5.3.3 Microphysiological System Market Challenges
- 5.3.4 Microphysiological System Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Microphysiological System Players by Revenue
- 6.1.1 Global Top Microphysiological System Players by Revenue (2021-2026)
- 6.1.2 Global Microphysiological System Revenue Market Share by Players (2021-2026)
- 6.2 Global Microphysiological System Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Microphysiological System Head Office and Area Served
- 6.4 Global Microphysiological System Players, Product Type & Application
- 6.5 Global Microphysiological System Manufacturers Established Date
- 6.6 Global Microphysiological System Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Microphysiological System Market Size (2021-2032)
- 7.2 North America Microphysiological System Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Microphysiological System Market Size by Country (2021-2026)
- 7.4 North America Microphysiological System Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Microphysiological System Market Size (2021-2032)
- 8.2 Europe Microphysiological System Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Microphysiological System Market Size by Country (2021-2026)
- 8.4 Europe Microphysiological System Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Microphysiological System Market Size (2021-2032)
- 9.2 Asia-Pacific Microphysiological System Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Microphysiological System Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Microphysiological System Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Microphysiological System Market Size (2021-2032)
- 10.2 South America Microphysiological System Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Microphysiological System Market Size by Country (2021-2026)
- 10.4 South America Microphysiological System Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Microphysiological System Market Size (2021-2032)
- 11.2 Middle East & Africa Microphysiological System Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Microphysiological System Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Microphysiological System Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Emulate
- 12.1.1 Emulate Company Information
- 12.1.2 Emulate Business Overview
- 12.1.3 Emulate Revenue in Microphysiological System Business (2021-2026)
- 12.1.4 Emulate Microphysiological System Product Portfolio
- 12.1.5 Emulate Recent Developments
- 12.2 Mimetas
- 12.2.1 Mimetas Company Information
- 12.2.2 Mimetas Business Overview
- 12.2.3 Mimetas Revenue in Microphysiological System Business (2021-2026)
- 12.2.4 Mimetas Microphysiological System Product Portfolio
- 12.2.5 Mimetas Recent Developments
- 12.3 TissUse
- 12.3.1 TissUse Company Information
- 12.3.2 TissUse Business Overview
- 12.3.3 TissUse Revenue in Microphysiological System Business (2021-2026)
- 12.3.4 TissUse Microphysiological System Product Portfolio
- 12.3.5 TissUse Recent Developments
- 12.4 InSphero
- 12.4.1 InSphero Company Information
- 12.4.2 InSphero Business Overview
- 12.4.3 InSphero Revenue in Microphysiological System Business (2021-2026)
- 12.4.4 InSphero Microphysiological System Product Portfolio
- 12.4.5 InSphero Recent Developments
- 12.5 Hesperos
- 12.5.1 Hesperos Company Information
- 12.5.2 Hesperos Business Overview
- 12.5.3 Hesperos Revenue in Microphysiological System Business (2021-2026)
- 12.5.4 Hesperos Microphysiological System Product Portfolio
- 12.5.5 Hesperos Recent Developments
- 12.6 CN Bio
- 12.6.1 CN Bio Company Information
- 12.6.2 CN Bio Business Overview
- 12.6.3 CN Bio Revenue in Microphysiological System Business (2021-2026)
- 12.6.4 CN Bio Microphysiological System Product Portfolio
- 12.6.5 CN Bio Recent Developments
- 12.7 TNO
- 12.7.1 TNO Company Information
- 12.7.2 TNO Business Overview
- 12.7.3 TNO Revenue in Microphysiological System Business (2021-2026)
- 12.7.4 TNO Microphysiological System Product Portfolio
- 12.7.5 TNO Recent Developments
- 12.8 28bio
- 12.8.1 28bio Company Information
- 12.8.2 28bio Business Overview
- 12.8.3 28bio Revenue in Microphysiological System Business (2021-2026)
- 12.8.4 28bio Microphysiological System Product Portfolio
- 12.8.5 28bio Recent Developments
- 12.9 Beijing Daxiang Biotech
- 12.9.1 Beijing Daxiang Biotech Company Information
- 12.9.2 Beijing Daxiang Biotech Business Overview
- 12.9.3 Beijing Daxiang Biotech Revenue in Microphysiological System Business (2021-2026)
- 12.9.4 Beijing Daxiang Biotech Microphysiological System Product Portfolio
- 12.9.5 Beijing Daxiang Biotech Recent Developments
- 12.10 Newcells Biotech
- 12.10.1 Newcells Biotech Company Information
- 12.10.2 Newcells Biotech Business Overview
- 12.10.3 Newcells Biotech Revenue in Microphysiological System Business (2021-2026)
- 12.10.4 Newcells Biotech Microphysiological System Product Portfolio
- 12.10.5 Newcells Biotech Recent Developments
- 12.11 Nortis (Quris-Al)
- 12.11.1 Nortis (Quris-Al) Company Information
- 12.11.2 Nortis (Quris-Al) Business Overview
- 12.11.3 Nortis (Quris-Al) Revenue in Microphysiological System Business (2021-2026)
- 12.11.4 Nortis (Quris-Al) Microphysiological System Product Portfolio
- 12.11.5 Nortis (Quris-Al) Recent Developments
- 12.12 Valo Health (TARA Biosystems)
- 12.12.1 Valo Health (TARA Biosystems) Company Information
- 12.12.2 Valo Health (TARA Biosystems) Business Overview
- 12.12.3 Valo Health (TARA Biosystems) Revenue in Microphysiological System Business (2021-2026)
- 12.12.4 Valo Health (TARA Biosystems) Microphysiological System Product Portfolio
- 12.12.5 Valo Health (TARA Biosystems) Recent Developments
- 12.13 Altis Biosystems
- 12.13.1 Altis Biosystems Company Information
- 12.13.2 Altis Biosystems Business Overview
- 12.13.3 Altis Biosystems Revenue in Microphysiological System Business (2021-2026)
- 12.13.4 Altis Biosystems Microphysiological System Product Portfolio
- 12.13.5 Altis Biosystems Recent Developments
- 12.14 Draper Laboratory
- 12.14.1 Draper Laboratory Company Information
- 12.14.2 Draper Laboratory Business Overview
- 12.14.3 Draper Laboratory Revenue in Microphysiological System Business (2021-2026)
- 12.14.4 Draper Laboratory Microphysiological System Product Portfolio
- 12.14.5 Draper Laboratory Recent Developments
- 12.15 Netri
- 12.15.1 Netri Company Information
- 12.15.2 Netri Business Overview
- 12.15.3 Netri Revenue in Microphysiological System Business (2021-2026)
- 12.15.4 Netri Microphysiological System Product Portfolio
- 12.15.5 Netri Recent Developments
- 12.16 Bi/ond
- 12.16.1 Bi/ond Company Information
- 12.16.2 Bi/ond Business Overview
- 12.16.3 Bi/ond Revenue in Microphysiological System Business (2021-2026)
- 12.16.4 Bi/ond Microphysiological System Product Portfolio
- 12.16.5 Bi/ond Recent Developments
- 12.17 ImmuONE
- 12.17.1 ImmuONE Company Information
- 12.17.2 ImmuONE Business Overview
- 12.17.3 ImmuONE Revenue in Microphysiological System Business (2021-2026)
- 12.17.4 ImmuONE Microphysiological System Product Portfolio
- 12.17.5 ImmuONE Recent Developments
- 12.18 AlveoliX
- 12.18.1 AlveoliX Company Information
- 12.18.2 AlveoliX Business Overview
- 12.18.3 AlveoliX Revenue in Microphysiological System Business (2021-2026)
- 12.18.4 AlveoliX Microphysiological System Product Portfolio
- 12.18.5 AlveoliX Recent Developments
- 12.19 Cherry Biotech
- 12.19.1 Cherry Biotech Company Information
- 12.19.2 Cherry Biotech Business Overview
- 12.19.3 Cherry Biotech Revenue in Microphysiological System Business (2021-2026)
- 12.19.4 Cherry Biotech Microphysiological System Product Portfolio
- 12.19.5 Cherry Biotech Recent Developments
- 12.20 Ananda Devices
- 12.20.1 Ananda Devices Company Information
- 12.20.2 Ananda Devices Business Overview
- 12.20.3 Ananda Devices Revenue in Microphysiological System Business (2021-2026)
- 12.20.4 Ananda Devices Microphysiological System Product Portfolio
- 12.20.5 Ananda Devices Recent Developments
- 12.21 Obatala Sciences
- 12.21.1 Obatala Sciences Company Information
- 12.21.2 Obatala Sciences Business Overview
- 12.21.3 Obatala Sciences Revenue in Microphysiological System Business (2021-2026)
- 12.21.4 Obatala Sciences Microphysiological System Product Portfolio
- 12.21.5 Obatala Sciences Recent Developments
- 12.22 BiomimX
- 12.22.1 BiomimX Company Information
- 12.22.2 BiomimX Business Overview
- 12.22.3 BiomimX Revenue in Microphysiological System Business (2021-2026)
- 12.22.4 BiomimX Microphysiological System Product Portfolio
- 12.22.5 BiomimX Recent Developments
- 12.23 React4life
- 12.23.1 React4life Company Information
- 12.23.2 React4life Business Overview
- 12.23.3 React4life Revenue in Microphysiological System Business (2021-2026)
- 12.23.4 React4life Microphysiological System Product Portfolio
- 12.23.5 React4life Recent Developments
- 12.24 Aracari Bio
- 12.24.1 Aracari Bio Company Information
- 12.24.2 Aracari Bio Business Overview
- 12.24.3 Aracari Bio Revenue in Microphysiological System Business (2021-2026)
- 12.24.4 Aracari Bio Microphysiological System Product Portfolio
- 12.24.5 Aracari Bio Recent Developments
- 12.25 StemPharm
- 12.25.1 StemPharm Company Information
- 12.25.2 StemPharm Business Overview
- 12.25.3 StemPharm Revenue in Microphysiological System Business (2021-2026)
- 12.25.4 StemPharm Microphysiological System Product Portfolio
- 12.25.5 StemPharm Recent Developments
- 12.26 SynVivo
- 12.26.1 SynVivo Company Information
- 12.26.2 SynVivo Business Overview
- 12.26.3 SynVivo Revenue in Microphysiological System Business (2021-2026)
- 12.26.4 SynVivo Microphysiological System Product Portfolio
- 12.26.5 SynVivo Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst